Health Risk Behaviors among HIV-Infected Youth in Bangkok, Thailand

Journal of Adolescent Health

Volumn 40, Issue 4, 2007, Pages 358.e1-358.e8

  Rongkavilit, Chokechai ^a   Naar King, Sylvie ^a   Chuenyam, Theshinee ^b   Wang, Bo ^a   Wright, Kathryn ^a   Phanuphak, Praphan ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

Author keywords

Adherence; Alcohol; Disclosure; HIV; Sexual risks; Substance; Thailand; Youth

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; ALCOHOL ABUSE; ARTICLE; CIGARETTE SMOKING; CONDOM; FEMALE; HEALTH HAZARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SAFE SEX; SEX DIFFERENCE; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; THAILAND; UNSAFE SEX;

EID: 33847692777     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2006.11.004     Document Type: Article

References (42)

1. UNIADS/WHO. AIDS epidemic update (2005) December
2. Thai Working Group on HIV/AIDS. Situations of AIDS in Thailand (2006), Ministry of Public Health, Thailand
3. Ruxrungtham K., Brown T., and Phanuphak P. HIV/AIDS in Asia. Lancet 364 (2004) 69-82
4. Murphy D.A., Belzer M., Durako S.J., Sarr M., Wilson C.M., and Muenz L.R. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Arch Pediatr Adolesc Med 159 (2005) 764-770
5. Diamond C., Richardson J.L., Milam J., et al. Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients. J Acquir Immune Defic Syndr 39 (2005) 211-218
6. Kalichman S.C., and Rompa D. HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy. Sex Transm Infect 79 (2003) 59-61
7. Aloisi M.S., Arici C., Balzano R., et al. Behavioral correlates of adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 31 suppl 3 (2002) S145-S148
8. Belzer M.E., Fuchs D.N., Luftman G.S., and Tucker D.J. Antiretroviral adherence issues among HIV-positive adolescents and young adults. J Adolesc Health 25 (1999) 316-319
9. Martinez J., Bell D., Camacho R., et al. Adherence to antiviral drug regimens in HIV-infected adolescent patients engaged in care in a comprehensive adolescent and young adult clinic. J Natl Med Assoc 92 (2000) 55-61
10. Murphy D.A., Wilson C.M., Durako S.J., Muenz L.R., and Belzer M. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care 13 (2001) 27-40
11. Lynch D.A., Krantz S., Russell J.M., Hornberger L.L., and Van Ness C.J. HIV infection: a retrospective analysis of adolescent high-risk behaviors. J Pediatr Health Care 14 (2000) 20-25
12. Hein K., Dell R., Futterman D., Rotheram-Borus M.J., and Shaffer N. Comparison of HIV+ and HIV- adolescents: risk factors and psychosocial determinants. Pediatrics 95 (1995) 96-104
13. Holland C.A., Ma Y., Moscicki B., Durako S.J., Levin L., and Wilson C.M. Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: findings of the REACH Study. Adolescent Medicine HIV/AIDS Research Network. Sex Transm Dis 27 (2000) 296-303
14. Vermund S.H., Wilson C.M., Rogers A.S., Partlow C., and Moscicki A.B. Sexually transmitted infections among HIV infected and HIV uninfected high-risk youth in the REACH study. Reaching for Excellence in Adolescent Care and Health. J Adolesc Health 29 (2001) 49-56
15. Mott F.L., and Haurin R.J. Linkages between sexual activity and alcohol and drug use among American adolescents. Fam Plann Perspect 20 (1988) 128-136
16. Walter H.J., Vaughan R.D., Ragin D.F., Cohall A.T., Kasen S., and Fullilove R.E. Prevalence and correlates of AIDS-risk behaviors among urban minority high school students. Prev Med 22 (1993) 813-824
17. Chesney M., Ickovics J., Chambers D., et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 12 (2000) 255-266
18. Moatti J.P., Carrieri M.P., Spire B., Gastaut J.A., Cassuto J.P., and Moreau J. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS 14 (2000) 151-155
19. Lucas G.M., Gebo K.A., Chaisson R.E., and Moore R.D. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 16 (2002) 767-774
20. Frey M.A., and Denyes M.J. Health and illness self-care in adolescents with IDDM: a test of Orem's theory. ANS Adv Nurs Sci 12 (1989) 67-75
21. Giordano T.P., Guzman D., Clark R., Charlebois E.D., and Bangsberg D.R. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin 5 (2004) 74-79
22. Naar-King S., Templin T., Wright K., et al. Psychosocial factors and medication adherence in HIV+ youth. AIDS Patient Care STDS 20 (2006) 44-47
23. Naar-King S., Frey M., Harris M., and Arfken C. Measuring adherence to treatment of paediatric HIV/AIDS. AIDS Care 17 (2005) 345-349
24. Carney M.A., Tennen H., Affleck G., Del Boca F.K., and Kranzler H.R. Levels and patterns of alcohol consumption using timeline follow-back, daily diaries and real-time "electronic interviews.". J Stud Alcohol 59 (1998) 447-454
25. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., and Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 68 (2000) 134-144
26. Naar-King S., Wright K., Parsons J.T., Frey M., Templin T., and Ondersma S. Transtheoretical model and substance use in HIV+ youth. AIDS Care 18 (2006) 839-845
27. Naar-King S., Wright K., Parsons J.T., et al. Healthy choices: motivational enhancement therapy for health risk behaviors in HIV+ youth. AIDS Educ Prev 18 (2006) 1-11
28. Paterson D.L., Swindells S., Mohr J., et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 133 (2000) 21-30
29. Flynn P.M., Rudy B.J., Douglas S.D., et al. Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy. J Infect Dis 190 (2004) 271-279
30. Nemes M.I., Carvalho H.B., and Souza M.F. Antiretroviral therapy adherence in Brazil. AIDS 18 Suppl 3 (2004) S15-S20
31. Laurent C., Diakhate N., Gueye N.F., et al. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS 16 (2002) 1363-1370
32. Laurent C., Ngom Gueye N.F., Ndour C.T., et al. Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. J Acquir Immune Defic Syndr 38 (2005) 14-17
33. Oyugi J.H., Byakika-Tusiime J., Charlebois E.D., et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr 36 (2004) 1100-1102
34. Akileswaran C., Lurie M.N., Flanigan T.P., and Mayer K.H. Lessons learned from use of highly active antiretroviral therapy in Africa. Clin Infect Dis 41 (2005) 376-385
35. Muangchana K, Prommoon W, Somton P. Antiretroviral drug taking behaviors of HIV/AIDS out-patients of Bamrasnaradura infectious disease insitute, Thailand, 2003 [WePeB5810]. In: XV International AIDS Conference. Bangkok, Thailand, 2004.
36. Beyrer C., Eiumtrakul S., Celentano D.D., Nelson K.E., Ruckphaopunt S., and Khamboonruang C. Same-sex behavior, sexually transmitted diseases and HIV risks among young northern Thai men. AIDS 9 (1995) 171-176
37. London A.S., VanLandingham M.J., and Grandjean N. Socio-demographic correlates, HIV/AIDS-related cofactors, and measures of same-sex sexual behaviour among northern Thai male soldiers. Health Transit Rev 7 (1997) 33-60
38. van Griensven F., Thanprasertsuk S., Jommaroeng R., et al. Evidence of a previously undocumented epidemic of HIV infection among men who have sex with men in Bangkok, Thailand. AIDS 19 (2005) 521-526
39. van Griensven F., Supawitkul S., Kilmarx P.H., et al. Rapid assessment of sexual behavior, drug use, human immunodeficiency virus, and sexually transmitted diseases in northern Thai youth using audio-computer-assisted self-interviewing and noninvasive specimen collection. Pediatrics 108 (2001) E13
40. UNIADS/WHO. Thailand: Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections Update (2004) December
41. van Griensven F., Varangrat A., Naorat S., et al. HIV surveillance among men who have sex with men populations in Thailand: evidence for high prevalence and incidence (abstract 919). Conference on Retroviruses and Opportunistic Infections (2006) Denver, CO
42. Ruangkanchanasetr S., Plitponkarnpim A., Hetrakul P., and Kongsakon R. Youth risk behavior survey: Bangkok, Thailand. J Adolesc Health 36 (2005) 227-235